Domenic J Ferrante insider trades: Finch Therapeutics Group (FNCH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Domenic reports to the SEC
and 2 more companies
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 23, 2021 | FNCH | ↑ Buy | 102,941 | $17.00 | $1.7M | Indirect | Mar 25, 2021 (2d) |
| Nov 22, 2010 | DPZ | ↓ Sell | 109,638 | $14.50 | $1.6M | Indirect | Nov 22, 2010 (0d) |
| Nov 11, 2010 | DPZ | ↓ Sell | 151,603 | $15.02 | $2.3M | Indirect | Nov 12, 2010 (1d) |
| Nov 2, 2010 | DPZ | ↓ Sell | 262,110 | $14.98 | $3.9M | Indirect | Nov 4, 2010 (2d) |
| Oct 22, 2010 | DPZ | ↓ Sell | 262,110 | $15.15 | $4.0M | Indirect | Oct 25, 2010 (3d) |
| Mar 18, 2010 | DPZ | ↓ Sell | 218,426 | $13.58 | $3.0M | Indirect | Mar 22, 2010 (4d) |
| Mar 11, 2010 | DPZ | ↓ Sell | 218,426 | $13.72 | $3.0M | Indirect | Mar 12, 2010 (1d) |
| Mar 4, 2010 | DPZ | ↓ Sell | 262,111 | $13.63 | $3.6M | Indirect | Mar 8, 2010 (4d) |
| Oct 1, 2008 | TKLC | ↓ Sell | 500,000 | $13.37 | $6.7M | Direct | Oct 3, 2008 (2d) |
| Nov 6, 2007 | NSPH | ↑ Buy | 892,857 | $14.00 | $12.5M | Indirect | Nov 8, 2007 (2d) |
| Oct 15, 2007 | TARG | ↑ Buy | 575,000 | $10.00 | $5.8M | Indirect | Oct 17, 2007 (2d) |
| Oct 5, 2007 | MAPP | ↑ Buy | 600,000 | $12.00 | $7.2M | Indirect | Oct 15, 2007 (10d) |
| Mar 10, 2006 | DPZ | ↓ Sell | 491,306 | $25.78 | $12.7M | Indirect | Mar 14, 2006 (4d) |
| Nov 28, 2005 | DPZ | ↓ Sell | 19,635 | $24.95 | $490K | Indirect | Nov 30, 2005 (2d) |
| Nov 21, 2005 | DPZ | ↓ Sell | 114,051 | $24.56 | $2.8M | Indirect | Nov 22, 2005 (1d) |
| Nov 17, 2005 | DPZ | ↓ Sell | 106,377 | $24.17 | $2.6M | Indirect | Nov 18, 2005 (1d) |
| Nov 11, 2005 | DPZ | ↓ Sell | 98,291 | $24.11 | $2.4M | Indirect | Nov 15, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Domenic J Ferrante's insider trades
Domenic J Ferrante is a director at Finch Therapeutics Group (FNCH). Since Nov 11, 2005, Domenic has reported 4 open-market purchases worth $27.2M and 13 sales worth $48.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (5 filings), other transactions (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FNCH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.